News & Analysis as of

Antitrust Provisions Abuse of Dominance

Wilson Sonsini Goodrich & Rosati

European Antitrust Bimonthly Bulletin – March/April 2025

The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which breaks down the major antitrust developments in Europe in the past two months into concise and actionable takeaways....more

Dacheng

China Monthly Antitrust Update: April 2025

Dacheng on

This monthly report outlines key developments in China’s antitrust sector for April. The following events merit special attention...more

A&O Shearman

EU leads global charge as abuse of dominance cases target Big Tech

A&O Shearman on

2024 saw a significant increase in the total fines imposed in abuse of dominance cases compared to 2023, reversing a trend of decline in recent years. The rise in fine volumes was spread across all regions of the world, with...more

A&O Shearman

Global antitrust enforcement report - 2025

A&O Shearman on

2024 saw a significant increase in overall global fines for antitrust enforcement, with total penalties for the jurisdictions surveyed in our report at USD6.7 billion, over double that of 2023 (USD2.9bn) and substantially...more

Wilson Sonsini Goodrich & Rosati

European Antitrust Bimonthly Bulletin – January/February 2025

The "European Antitrust Bimonthly Bulletin" breaks down the major antitrust developments in Europe during the past two months into concise and actionable takeaways....more

Sheppard Mullin Richter & Hampton LLP

Amending New York’s Donnelly Act: If at First You Don’t Succeed, Try, Try, and Try Again

A proposed amendment to New York’s Donnelly Act, introduced earlier this month, would significantly broaden the scope of the antitrust statute enacted in 1899. New York Senate Bill 335, titled the “Twenty-First Century...more

Smart & Biggar

Competition Tribunal refuses JAMP leave to commence ustekinumab abuse of dominance application

Smart & Biggar on

As we previously reported, JAMP sought leave to commence an application against Janssen under the abuse of dominance provisions of the Competition Act (the Act), relating to ustekinumab (Janssen’s STELARA and FINLIUS). This...more

Morgan Lewis

CLRC Staff Releases Recommendations for California Antitrust Law Reforms

Morgan Lewis on

The California Law Revision Commission (CLRC or Commission) staff on January 13, 2025 published its recommendations to the Commission regarding potential reforms to the state’s existing antitrust laws....more

McDermott Will & Emery

Intel’s EUR 1 Billion Fine Overturned: ECJ’s Landmark Ruling

McDermott Will & Emery on

On October 24, 2024, the European Court of Justice (ECJ) confirmed the annulment by the General Court (GC) of the European Commission’s (EC) decision to impose a EUR 1.06 billion fine on Intel for the abuse of a dominant...more

Goodwin

The General Court of the European Union Annuls a €1.5 Billion Fine Against Google AdSense

Goodwin on

In its 18 September 2024 ruling, the General Court of the European Union annulled the €1.5 billion fine that the European Commission had imposed on Google in 2019 for allegedly abusing its dominant position in online search...more

Goodwin

Antitrust and Competition Life Sciences Quarterly Update Q2 2024

Goodwin on

To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more

Goodwin

In a Landmark Judgment, Top European Court Curbs European Commission’s Ability to Review “Killer Acquisitions”

Goodwin on

On 3 September 2024, the European Court of Justice (ECJ) ruled that the European Commission (Commission) cannot encourage or accept referrals for below-threshold deals from national competition authorities if those...more

Hogan Lovells

Commission investigation into termination of pipeline drug: what next for R&D decision-making?

Hogan Lovells on

The European Commission has opened a formal investigation into whether Zoetis, a US animal health company, has acted in breach of the abuse of dominance rules by terminating development of a pipeline drug: when does...more

Davies Ward Phillips & Vineberg LLP

New Excessive and Unfair Pricing Provisions in Force in Canada’s Competition Act: Risk and Compliance Considerations

Canada’s Competition Act was amended effective December 15, 2023 to both (i) establish a new, more expansive framework for challenging anti-competitive conduct by dominant firms and (ii) specifically provide that it is an...more

Stikeman Elliott LLP

New Sweeping Competition Powers for the Canadian Government

Stikeman Elliott LLP on

With the passing of Bill C-56, the most recent in an ongoing series of amendments to the Competition Act have now been enacted (with more expected to follow). The Commissioner of Competition has been pushing for amendments to...more

Stikeman Elliott LLP

Government’s “Generational Changes to Competition Law in Canada” Increase Risks for Canadian Businesses

Stikeman Elliott LLP on

On November 28, 2023 the Canadian government unveiled another round of amendments to the Competition Act that had been previewed in its Fall Economic Statement the previous week. These changes, together with several...more

Stikeman Elliott LLP

Competition Global Guide: Canada Q&A - Merger notification flowchart: Canada

Stikeman Elliott LLP on

A Q&A guide to competition law in Canada. The Q&A provides a high-level overview of the antitrust and competition law rules for restraints of trade and dominance, merger control and the legal approach to joint ventures. ...more

Morrison & Foerster LLP

Quarterly Cartel Catch-Up: Recent Developments in Criminal Antitrust for Busy Corporate Counsel ‒ 2nd Quarter 2023

At this mid-point of 2023, and now several months on from the ABA’s Spring Antitrust conference, there have been several notable developments concerning cartel enforcement, as new leadership settles in at the U.S. Department...more

Goodwin

REMICADE Antitrust Settlement Receives Final Approval

Goodwin on

In 2017, three indirect-purchaser antitrust class actions were filed against Johnson & Johnson and Janssen Biotech, Inc., alleging that they engaged in anticompetitive conduct relating to the sale and marketing of J&J’s...more

Jones Day

Towards a Less Effects-Based Approach? European Commission Takes Action to Amend EU Framework on Exclusionary Abuses of Dominance

Jones Day on

In Short - The Situation: On 27 March 2023, the European Commission ("Commission") published a Communication amending its 2008 Guidance on enforcement priorities concerning exclusionary abuses ("amended 2008 Guidance...more

Kramer Levin Naftalis & Frankel LLP

CJEU Towercast Judgment: The Prohibition of Abuse of a Dominant Position Allows Ex Post Control of Mergers

On March 16, in a preliminary ruling requested by the Paris Court of Appeal regarding Towercast’s appeal of the French Competition Authority’s decision in the TDF case, the Court of Justice of the European Union decided ...more

Hogan Lovells

Antitrust restrictions on price increases?

Hogan Lovells on

Antitrust law may restrict price increases if the preconditions of a pricing abuse are met. However, decision practice on this topic is scarce. Therefore, EDEKA’s petition for a preliminary injunction filed against Coca-Cola...more

Stikeman Elliott LLP

Canada’s Competition Act Amendments: Making It Riskier to Compete on Price?

Stikeman Elliott LLP on

One of the recent amendments to the Competition Act has the potential to seriously chill price competition by leading Canadian businesses....more

Hogan Lovells

The revision of the chinese anti-monopoly law – abuse of dominance, of IPR and of administrative powers

Hogan Lovells on

There are relatively few changes in the draft regulations implementing the revised Anti-Monopoly Law in the areas of abuse of dominance, abuse of IPRs, and abuse of administrative powers. While mainly platform operators are...more

Hogan Lovells

The revision of the Chinese Anti-Monopoly Law – to agree or not to agree

Hogan Lovells on

The draft Regulation Prohibiting Monopoly Agreements is a key part of the Anti-Monopoly Law reform package. While the expansion of the cartel prohibition to include third parties may not come as a surprise, the introduction...more

45 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide